Index RUT
P/E -
EPS (ttm) -2.77
Insider Own 5.03%
Shs Outstand 160.09M
Perf Week 2.02%
Market Cap 1.86B
Forward P/E -
EPS next Y -0.27
Insider Trans -0.94%
Shs Float 152.03M
Perf Month 8.59%
Income -294.33M
PEG -
EPS next Q -0.90
Inst Own 52.36%
Short Float 20.06%
Perf Quarter -40.53%
Sales 987.67M
P/S 1.89
EPS this Y 81.70%
Inst Trans 2.80%
Short Ratio 3.52
Perf Half Y 107.31%
Book/sh -2.70
P/B -
EPS next Y 72.53%
ROA -16.80%
Short Interest 30.50M
Perf Year 19.40%
Cash/sh 6.62
P/C 1.76
EPS next 5Y 37.90%
ROE -
52W Range 3.53 - 23.86
Perf YTD 142.29%
Dividend Est. -
P/FCF -
EPS past 5Y 11.55%
ROI -
52W High -51.26%
Beta 2.05
Dividend TTM -
Quick Ratio 1.03
Sales past 5Y 513.29%
Gross Margin 66.32%
52W Low 229.24%
ATR (14) 1.05
Dividend Ex-Date Dec 13, 2007
Current Ratio 1.04
EPS Y/Y TTM 62.96%
Oper. Margin -28.95%
RSI (14) 44.54
Volatility 10.44% 8.55%
Employees 1543
Debt/Eq -
Sales Y/Y TTM -38.17%
Profit Margin -29.80%
Recom 2.60
Target Price 18.00
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q 70.87%
Payout -
Rel Volume 0.32
Prev Close 11.95
Sales Surprise -9.40%
EPS Surprise -40.72%
Sales Q/Q -2.11%
Earnings Aug 08 BMO
Avg Volume 8.66M
Price 11.63
SMA20 -4.26%
SMA50 -10.50%
SMA200 38.14%
Trades
Volume 2,759,304
Change -2.68%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-30-24 Downgrade
JP Morgan
Neutral → Underweight
$8
May-10-24 Upgrade
JP Morgan
Underweight → Neutral
May-10-24 Upgrade
BofA Securities
Underperform → Neutral
$4 → $12
Aug-09-23 Upgrade
B. Riley Securities
Neutral → Buy
$15
Apr-20-23 Downgrade
TD Cowen
Outperform → Market Perform
$55 → $10
Mar-01-23 Downgrade
B. Riley Securities
Buy → Neutral
$29 → $10
Jan-09-23 Reiterated
B. Riley Securities
Buy
$74 → $37
Dec-30-22 Reiterated
H.C. Wainwright
Buy
$207 → $110
Dec-02-22 Initiated
Jefferies
Hold
Sep-22-22 Downgrade
JP Morgan
Neutral → Underweight
$132 → $27
May-20-22 Initiated
BofA Securities
Underperform
$35
Feb-23-22 Reiterated
B. Riley Securities
Buy
$315 → $265
Feb-22-22 Resumed
Jefferies
Buy
$198
Jan-21-22 Initiated
Cowen
Outperform
$150
May-12-21 Downgrade
JP Morgan
Overweight → Neutral
$285 → $161
Dec-14-20 Initiated
Jefferies
Buy
$200
Aug-06-20 Reiterated
H.C. Wainwright
Buy
$132 → $290
Aug-05-20 Upgrade
JP Morgan
Neutral → Overweight
$275
Aug-05-20 Downgrade
Ladenburg Thalmann
Neutral → Sell
$105
Jul-16-20 Reiterated
H.C. Wainwright
Buy
$101 → $132
Show Previous Ratings
Sep-05-24 11:44AM
(Investor's Business Daily)
10:00AM
Sep-04-24 09:25AM
09:15AM
Sep-03-24 09:35AM
10:53AM
Loading…
Sep-02-24 10:53AM
(Pharmaceutical Technology)
07:34AM
(Pharmaceutical Business Review)
Aug-30-24 04:47PM
(Yahoo Finance Video) +8.60%
04:19PM
04:06PM
(Associated Press Finance)
Aug-29-24 12:00PM
Aug-28-24 09:00AM
Aug-24-24 11:20AM
Aug-22-24 02:33PM
01:41PM
12:08PM
Loading…
Aug-19-24 12:08PM
(Investor's Business Daily) +7.25%
Aug-14-24 09:00AM
Aug-09-24 11:09AM
Aug-08-24 12:08PM
(Yahoo Finance Video) +9.06%
09:15AM
08:11AM
(Associated Press Finance)
08:02AM
07:47AM
07:20AM
Aug-05-24 10:19AM
Aug-03-24 05:29AM
Aug-01-24 05:45PM
09:25AM
08:15AM
(Investor's Business Daily)
Jul-31-24 11:52AM
04:55PM
Loading…
Jul-30-24 04:55PM
(Yahoo Finance Video) -25.70%
04:05PM
Jul-29-24 09:00AM
Jul-25-24 01:28PM
(Investor's Business Daily) +8.25%
Jul-23-24 09:41AM
Jul-16-24 09:00AM
Jul-15-24 09:30AM
Jul-08-24 05:45PM
Jul-03-24 06:55AM
Jul-02-24 08:30AM
Jul-01-24 11:00PM
07:38AM
Jun-29-24 08:55AM
08:35AM
Jun-28-24 05:45PM
06:30AM
Jun-27-24 02:21PM
Jun-25-24 07:00PM
04:37PM
11:42AM
06:33AM
(Pharmaceutical Technology)
Jun-24-24 09:18AM
09:00AM
Jun-22-24 03:42AM
Jun-20-24 05:45PM
Jun-18-24 10:29AM
05:52AM
(Pharmaceutical Technology)
Jun-17-24 12:02PM
04:32AM
(Pharmaceutical Technology)
Jun-14-24 02:05PM
04:55AM
Jun-13-24 11:02AM
Jun-11-24 06:00AM
05:10AM
Jun-10-24 09:00AM
Jun-07-24 07:30AM
Jun-06-24 04:37PM
04:15PM
(Investor's Business Daily)
11:38AM
10:48AM
09:58AM
09:28AM
Jun-05-24 04:51PM
Jun-04-24 06:00AM
Jun-03-24 05:43PM
(Yahoo Finance Video) +21.22%
03:41PM
01:23PM
Jun-01-24 06:01AM
May-31-24 06:57AM
May-30-24 09:25AM
May-28-24 09:00AM
May-24-24 05:55PM
08:15AM
May-23-24 12:45PM
(The Wall Street Journal)
06:45AM
May-22-24 10:48AM
09:45AM
05:50AM
May-21-24 09:01AM
06:27AM
May-20-24 03:29PM
02:31PM
01:53PM
Hedge Fund and Insider Trading News: Ray Dalio, Michael Burry, David Tepper, Elliott Management, Greenlight Capital, Ghisallo Capital Management, Millennium Management, Nextnav Inc (NN), Williams-Sonoma, Inc. (WSM), and More
(Insider Monkey)
01:37PM
07:40AM
07:39AM
06:35AM
May-19-24 08:49AM
May-18-24 07:35AM
May-17-24 06:45AM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Trizzino John EVP, CCO and CBO Aug 19 '24 Option Exercise 0.00 655 0 28,627 Aug 21 04:47 PM Kelly James Patrick EVP, CFO and Treasurer Aug 16 '24 Option Exercise 12.96 2,367 30,676 15,652 Aug 20 05:06 PM YOUNG JAMES F Director Jun 21 '24 Sale 14.09 7,500 105,675 61,760 Jun 25 04:12 PM YOUNG JAMES F Director Jun 18 '24 Sale 13.72 7,500 102,881 69,260 Jun 21 04:21 PM Dubovsky Filip President, R&D Jun 17 '24 Option Exercise 6.18 13,904 85,911 80,517 Jun 20 05:08 PM Dubovsky Filip President, R&D Jun 17 '24 Sale 14.47 13,904 201,164 66,613 Jun 20 05:08 PM MCGLYNN MARGARET G Director Jun 12 '24 Option Exercise 0.00 6,670 0 10,470 Jun 14 04:14 PM Alton Gregg H Director Jun 12 '24 Option Exercise 0.00 6,670 0 10,470 Jun 14 04:11 PM DOUGLAS RICHARD Director Jun 12 '24 Option Exercise 0.00 6,670 0 43,920 Jun 14 04:10 PM King Rachel K. Director Jun 12 '24 Option Exercise 0.00 6,670 0 18,920 Jun 14 04:07 PM MOTT DAVID M Director Jun 12 '24 Option Exercise 0.00 6,670 0 50,470 Jun 14 04:06 PM Rodgers Richard J Director Jun 12 '24 Option Exercise 0.00 6,670 0 10,470 Jun 14 04:05 PM YOUNG JAMES F Director Jun 12 '24 Option Exercise 0.00 6,670 0 76,760 Jun 14 04:01 PM Dubovsky Filip President, R&D May 14 '24 Option Exercise 6.97 19,652 136,974 86,265 May 15 09:15 PM Dubovsky Filip President, R&D May 14 '24 Sale 13.90 47,312 657,637 38,953 May 15 09:15 PM O'Hara Elaine EVP, Chief Strategy Officer Mar 01 '24 Option Exercise 5.39 19,600 105,644 19,600 Mar 05 07:30 PM Dubovsky Filip President, R&D Dec 14 '23 Option Exercise 5.69 2,833 16,120 55,150 Dec 18 05:00 PM Dubovsky Filip President, R&D Nov 05 '23 Option Exercise 7.06 1,400 9,884 52,994 Nov 07 05:30 PM Dubovsky Filip President, R&D Sep 16 '23 Option Exercise 7.71 12,644 97,485 57,702 Sep 19 05:16 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite